WASHINGTON, DC USA (UroToday.com) - Dr. Francisco Cruz and co-workers from Porto, Portugal related further experience with intra-trigonal onabotulinum toxin A in 14 women with IC/BPS refractory to first-line treatments. Ten trigonal sites were injected with a total dose of 100 units. All patients reported subjective improvement following injection which persisted for 9-10 months. There was no tachyphylaxis, and injections were repeated for a total of 4 times with similar results. There were no episodes of urinary retention.
Presented by Francesco Cruz, MD, PhD, et al. at the American Urological Association (AUA) Annual Meeting - May 14 - 19, 2011 - Walter E. Washington Convention Center, Washington, DC USA
Reported for UroToday by Philip M. Hanno, MD, MPH, Professor of Urology in the Division of Urology at the Hospital of the University of Pennsylvania.
The opinions expressed in this article are those of the UroToday.com Contributing Editor and do not necessarily reflect the viewpoints of the American Urological Association.
View Full AUA 2011 Meeting Coverage
